Capital Research Global Investors 13D and 13G filings for Structure Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-13 11:32 am Sale | 2025-03-31 | 13G | Structure Therapeutics Inc. GPCR | Capital Research Global Investors | 6,492,435 3.800% | -4,098,915 (-38.70%) | Filing |
| 2024-11-12 12:52 pm Purchase | 2024-11-07 | 13G | Structure Therapeutics Inc. GPCR | Capital Research Global Investors | 10,591,350 6.200% | 10,591,350 (New Position) | Filing |